Earning
Lilly Expands Obesity Drug Range Amid Safety Trials
Eli Lilly is aggressively pursuing advancements in the field of obesity treatment, accelerating the development of an oral medication option ...
Moderna Reports $1.3B Loss and Cuts Back Production Amid Sales Dip
Moderna, once propelled to pharmaceutical prominence by its lucrative COVID-19 vaccine sales, now grapples with a decline in demand and ...
BMS Layoffs Over 100 Employees Lose Jobs After Earnings Miss
Bristol Myers Squibb, a prominent pharmaceutical company headquartered in New Jersey, has undertaken a significant reorganization of its financial structure ...
Teva Aims for Growth by 2027 After $4.25B Opioid Settlement
Teva Pharmaceutical is shifting its focus back to its core businesses in generics and biosimilars, seeing promising opportunities in both ...
Sanofi Reports ‘Solid’ Q2 Performance with 3 Ongoing Launches and Dupixent Nearing €10B Milestone
Sanofi, a leading pharmaceutical company, is navigating the challenges posed by the entry of generic versions of its drug Aubagio ...
Bayer anticipates a more bleak 2023 as decreased glyphosate sales support the argument for a separation
As calls for a business separation at Bayer grow louder, the company’s weedkiller performance is providing further support for the ...
